US Edition
FDA SIDE EFFECTS UPDATE: Gadolinium Contrast Agents (GBCAs) and Lung Problems - MedShadow Foundation | Independent Health & Wellness Journalism
Summary by MedShadow
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
FDA SIDE EFFECTS UPDATE: Gadolinium Contrast Agents (GBCAs) and Lung Problems - MedShadow Foundation | Independent Health & Wellness Journalism
Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects of your medications. In this installment, we’re highlighting safety updates concerning Dotarem, Elucirem, Eovist, Gadavist, Multihance, Prohance, and Omniscan. How to Read This Report This report is prepared using the most recent information posted in the SrLC database. It highlights recent saf…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
